Glandular-cystic hyperplasia of the endometrium. Causes, symptoms, therapy
is a fairly serious gynecological pathology. Lining the uterine cavity tissue (endometrium) starts due to various reasons to grow, increase in volume, bleed.
Types of disease
There are several types of this disease. Thus, a woman may develop simple, atypical, glandular-fibrous or glandular-cystic hyperplasia of the endometrium. In the first case, a thickening of the tissue layer occurs without structural changes in the cells. Atypical form is considered precancerous, in this case, the probability of cancer is about 10-15%. In the case of the fibrous type, the glandular polyp of the endometrium is most often formed, which is treated surgically. The presence of benign tumors in the uterus in medical practice is quite common.
Glandular-cystic hyperplasia of the endometrium. Causes, symptoms
These violations, as a rule, develop on the basis of significant hormonal changes in the body. Often the disease manifests itself during menopause and in adolescent girls. Overweight, anovulation, amenorrhea, and follicular cysts may also contribute to the development of pathology. Glandular-cystic hyperplasia of the endometrium is manifested primarily by bleeding. They can be both abundant and insignificant - depending on various factors. As a result of blood loss, symptoms such as a decrease in the level of hemoglobin in the blood, dizziness, and weakness may occur.
Experts note that glandular-cystic hyperplasia of the endometrium may be asymptomatic or accompanied by pain in the lower abdomen, arising irregularly. These phenomena significantly complicate the diagnosis. If hyperplastic changes are suspected, doctors prescribe hysteroscopy; An ultrasound scan is performed to establish the presence or absence of polyps. In the absence of ovulation on the background of the pathology of the disease is accompanied by infertility.
Glandular-cystic hyperplasia of the endometrium. Treatment
Therapy of this pathology is prescribed individually and depends on various factors. In particular, when prescribing treatment, the patient's age, general health, build, weight, desire to have children afterwards, the presence of any chronic diseases are taken into account. Due to the fact that the development of the disease is most often caused by hormonal disorders, therapy with appropriate drugs (progestogens and progestins) is prescribed. In the course of treatment, the removal of polyps (if available) and hyperplastic tissue is also performed. This procedure (for recurrent disease) is performed every six months. In this case, a biopsy is required, confirming the fact that there is no transformation into a cancerous form. In the case of the atypical form of the disease, the gynecologist-oncologist deals with therapy. In the presence of a therapeutic effect of hormonal treatment, experts try not to take extreme measures.